
Resources|Articles|November 8, 2024
The rewards of planning ahead: designing for full GMP production at pilot scale
Author(s)Avantor
Can biopharma manufacturers avoid extra costs, potential problems and wasted production time by designing a fully compliant (cGMP) manufacturing process early on? This article explores where planning ahead, using compendial raw materials of the highest quality and purity, can yield substantial benefits to both productivity and patient safety.
Trending on Pharmaceutical Technology
1
PharmTech Weekly Roundup—June 5, 2026
2
EMA Collaborates with African Regulators on Ebola Treatments
3
A Pharma Manufacturing Blueprint from Delaware’s Innovation Vision
4
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
5